Bank of Montreal
MACK

Bank of Montreal’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Bank of Montreal’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-736
Closed -$5K – 5013
2018
Q1 		$5K Hold
736
– – ﹤0.01% 3940
2017
Q4 		$6K Hold
736
– – ﹤0.01% 3910
2017
Q3 		$8K Sell
736
-1,640
-69% -$17.2K ﹤0.01% 3793
2017
Q2 		$23K Sell
2,376
-91
-4% -$1.86K ﹤0.01% 3497
2017
Q1 		$60K Sell
2,467
-187
-7% -$4.68K ﹤0.01% 3017
2016
Q4 		$115K Sell
2,654
-217
-8% -$9.25K ﹤0.01% 2767
2016
Q3 		$144K Buy
2,871
+1,170
+69% +$48.6K ﹤0.01% 2592
2016
Q2 		$73K Buy
1,701
+417
+32% +$22.7K ﹤0.01% 2933
2016
Q1 		$84K Hold
1,284
– – ﹤0.01% 2870
2015
Q4 		$80K Buy
1,284
+31
+2% +$2.18K ﹤0.01% 2864
2015
Q3 		$84K Buy
1,253
+274
+28% +$22.4K ﹤0.01% 2711
2015
Q2 		$95K Hold
979
– – ﹤0.01% 2772
2015
Q1 		$92K Hold
979
– – ﹤0.01% 2670
2014
Q4 		$87K Hold
979
– – ﹤0.01% 2837
2014
Q3 		$68K Sell
979
-59
-6% -$3.15K ﹤0.01% 3014
2014
Q2 		$59K Buy
1,038
+301
+41% +$15.3K ﹤0.01% 3128
2014
Q1 		$29K Buy
737
+292
+66% +$12.5K ﹤0.01% 3355
2013
Q4 		$18K Hold
445
– – ﹤0.01% 3264
2013
Q3 		$13K Buy
445
+318
+250% +$11.1K ﹤0.01% 3363
2013
Q2 		$7K Buy
+127
New +$5.57K ﹤0.01% 3397

Other funds holding MACK

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
WIM
Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of Montreal's MACK Position: Q2 2018 in Review

Bank of Montreal sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q2 2018, closing a stake of 736 shares — an estimated $5K sold.

Bank of Montreal first reported a position in MACK in Q2 2013 and held it in 20 quarters. The position peaked at $144K in Q3 2016. 76 funds tracked by Wall St. Rank hold MACK as of Q2 2018.

  • Bank of Montreal reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Bank of Montreal sold 736 Merrimack Pharmaceuticals, Inc. shares in Q2 2018, an estimated $5K.
  • Bank of Montreal first reported a position in Merrimack Pharmaceuticals, Inc. in Q2 2013 and held it in 20 quarters.
  • Bank of Montreal's Merrimack Pharmaceuticals, Inc. position peaked at $144K in Q3 2016.
  • 76 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q2 2018.

Based on Bank of Montreal's 13F filing for Q2 2018, filed 16 Jul 2018.